4.7 Article

Dual-targeting prodrug nanotheranostics for NIR-II fluorescence imaging-guided photo-immunotherapy of glioblastoma

Journal

ACTA PHARMACEUTICA SINICA B
Volume 12, Issue 9, Pages 3486-3497

Publisher

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2022.05.016

Keywords

Glioblastoma; Dual targeting; Photothermal therapy; NIR-II fluorescence imaging; Precise immunotherapy

Funding

  1. National Natural Science Foundation of China [22074043, 22174047, 32050410287]
  2. Science and Technology Commission of Shanghai Municipality (China) [20142202800]
  3. China Postdoctoral Science Foundation [2021M700157]
  4. Shanghai Post-Doctoral Excellence Program (China) [2021424]

Ask authors/readers for more resources

The study presents a dual-targeting nanotheranostic for precise photo-immunotherapy of glioblastoma (GBM). The nanotheranostic can deliver drugs to the tumor site and induce a photothermal effect, enhancing the therapeutic effect.
Glioblastoma (GBM) therapy is severely impaired by the blood-brain barrier (BBB) and invasive tumor growth in the central nervous system. To improve GBM therapy, we herein presented a dual-targeting nanotheranostic for second near-infrared (NIR-II) fluorescence imaging-guided photo-immunotherapy. Firstly, a NIR-II fluorophore MRP bearing donor-acceptor-donor (D-A-D) backbone was synthesized. Then, the prodrug nanotheranostics were prepared by self-assembling MRP with a pro -drug of JQ1 (JPC) and T7 ligand-modified PEG5k-DSPE. T7 can cross the BBB for tumor-targeted de-livery of JPC and MRP. JQ1 could be restored from JPC at the tumor site for suppressing interferon gamma-inducible programmed death ligand 1 expression in the tumor cells. MRP could generate NIR-II fluorescence to navigate 808 nm laser, induce a photothermal effect to trigger in-situ antigen release at the tumor site, and ultimately elicit antitumor immunogenicity. Photo-immunotherapy with JPC and MRP dual-loaded nanoparticles remarkably inhibited GBM tumor growth in vivo. The dual-targeting na-notheranostic might represent a novel nanoplatform for precise photo-immunotherapy of GBM.(c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available